Cacan R, Duvet S, Kmiécik D, Labiau O, Mir A M, Verbert A
Laboratoire de Chimie Biologique, UMR 111 du CNRS/USTL, Université des Sciences et Technologies de Lille, France.
Biochimie. 1998 Jan;80(1):59-68. doi: 10.1016/s0300-9084(98)80057-6.
For the past 15 years, it has appeared increasingly evident that the N-glycosylation process was accompanied by the release of oligomannoside type oligosaccharides. This material is constituted of oligosaccharide-phosphates and of neutral oligosaccharides possessing one GlcNAc (OS-Gn1) or two GlcNAc (OS-Gn2) at the reducing end. It has been demonstrated that oligosaccharide-phosphates originated from the cleavage by a specific pyrophosphatase, of non-glycosylated cytosolic faced oligosaccharide-PP-Dol and chiefly the Man5GlcNAc2-PP-Dol. The Man5GlcNAc2-P, as the main product, is recovered in the cytosolic compartment and is further degraded to Man5GlcNAc1 by as for yet not depicted enzymes. In contrast, OS-Gn2 produced from hydrolysis of oligosaccharide-PP-Dol (presumably as a transfer reaction onto water) when the amount of protein acceptor is limiting, are generated into the lumen of rough endoplasmic reticulum (ER). They are further submitted to processing alpha-glucosidases and rough ER mannosidase and are (mainly as Man8GlcNAc2) exported into the cytosolic compartment. This material is further degraded into a single component, the Man5GlcNAc1: Man alpha 1-2Man alpha 1-2Man alpha 1-3 (Man alpha 1-6)Man beta 1-4GlcNAc by the sequential action of a cytosolic neutral chitobiase followed by cytosolic mannosidase. Furthermore, OS-Gn1 could have a dual origin: on the one hand, they originate from OS-Gn2 by the cytosolic degradation pathway indicated above; on the other hand, we will discuss a possible origin from the degradation or remodeling of newly synthesized glycoproteins. Considered first as a minor phenomenon, these observations have lead to the concept of intracellular oligomannoside trafficking, a process which results from more fundamental phenomena such as the control of the dolichol cycle, and the so-called quality-control of glycoprotein. In this review, we would like to describe the evolution of ideas on the origin, intracellular trafficking and putative roles of these oligomannosides released during the N-glycosylation process. We propose that these early stage 'glyco-deglyco' processes represent a way of control of N-glycosylation and of the fate of N-glycoproteins.
在过去的15年里,越来越明显的是,N-糖基化过程伴随着低聚甘露糖型寡糖的释放。这种物质由寡糖磷酸酯和在还原端含有一个GlcNAc(OS-Gn1)或两个GlcNAc(OS-Gn2)的中性寡糖组成。已经证明,寡糖磷酸酯起源于一种特定焦磷酸酶对非糖基化的面向胞质的寡糖-PP-Dol(主要是Man5GlcNAc2-PP-Dol)的切割。作为主要产物的Man5GlcNAc2-P在胞质区室中被回收,并通过尚未描述的酶进一步降解为Man5GlcNAc1。相反,当蛋白质受体的量有限时,由寡糖-PP-Dol水解产生的OS-Gn2(可能是作为转移到水上的反应)在糙面内质网(ER)腔中产生。它们进一步接受α-葡萄糖苷酶和糙面内质网甘露糖苷酶的加工,并(主要以Man8GlcNAc2的形式)输出到胞质区室。这种物质通过胞质中性壳二糖酶随后是胞质甘露糖苷酶的顺序作用进一步降解为单一成分Man5GlcNAc1:Manα1-2Manα1-2Manα1-3(Manα1-6)Manβ1-4GlcNAc。此外,OS-Gn1可能有双重来源:一方面,它们通过上述胞质降解途径起源于OS-Gn2;另一方面,我们将讨论它们可能起源于新合成糖蛋白的降解或重塑。这些观察结果最初被视为一种次要现象,导致了细胞内低聚甘露糖转运的概念,这一过程源于更基本的现象,如多萜醇循环的控制和糖蛋白的所谓质量控制。在这篇综述中,我们想描述关于这些N-糖基化过程中释放的低聚甘露糖的起源、细胞内转运和假定作用的观点的演变。我们提出,这些早期的“糖基-去糖基”过程代表了一种控制N-糖基化和N-糖蛋白命运的方式。